As part of its effort to advocate against Medicare physician payment cuts, the American Medical Association (AMA) is seeking 2022 Merit-based Incentive Payment System (MIPS) scoring and payment adjustment information from participating clinicians.
Interested clinicians or groups are encouraged to email de-identified final score and payment adjustment information to Zach Smith, American College of Radiology® (ACR®) Senior Quality Programs Specialist, by Sept. 22. The information will be relayed to the AMA. Sharing this information through the College will help ACR’s efforts to communicate radiologists’ concerns to the Centers for Medicare and Medicaid Services (CMS) and Congress.
CMS released 2022 Merit-based Incentive MIPS scoring feedback Aug 10. This score determines whether a MIPS-eligible group or clinician receives a positive, neutral or negative payment adjustment during the 2024 payment year. If any errors are detected in the final score, it is recommended that participants submit a targeted review request to CMS as soon as possible. The deadline for a targeted review is Oct. 9.
If you have questions or would like more information about MIPS participation scoring, contact Zach Smith.
Make America Healthy Again
President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.
Read moreScope of Practice Bills Introduced At State Legislative Level
The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.
Read moreACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint
The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.
Read more